Blue Sail Medical Co., Ltd (SHE: 002382) has announced that its wholly owned subsidiary, Blue Sail Biosensors Medical Technology, has secured strategic investments totaling RMB 900 million from Capital Health Industry (Beijing) Fund and two other investors. The funds will be allocated to enhance product research and development as well as to expand manufacturing capacity.- Flcube.com
Recent news:
-
Three Senior Executives of Henan Topfond Pharmaceutical Under Investigation -
Leman Biotech Enters Zhongshan Life Science Park to Accelerate CAR-T Innovation -
BRL Medicine Inc. Secures Nearly $30 Million in B+ Round Financing to Advance Pipeline -
Chinese Biopharma Bio-Bank Corp. Aims for HKEX IPO, Focused on PDGF Therapies -
HutchMed Anticipates Milestone Payment as Takeda Launches Fruzaqla in Japan for CRC
